The role of 5-fluorouracil (5-FU) reintroduction with irinotecan or oxaliplatin in truly 5-FU-refractory advanced colorectal cancer patients.

Scartozzi, M; Sobrero, A; Gasparini, G; Berardi, R; Catalano, V; Graziano, F; Barni, S; Zaniboni, A; Beretta, G D; Labianca, R; Cascinu, S

Scartozzi, M; Sobrero, A; Gasparini, G; Berardi, R; Catalano, V; Graziano, F; Barni, S; Zaniboni, A; Beretta, G D; Labianca, R; Cascinu, S.

Affiliation

Scartozzi M; Clinica di Oncologia Medica, Azienda Ospedaliera Umberto I-Università Politecnica delle Marche, Ancona, Italy.

Oncology ; 68(2-3): 212-6, 2005.

Article in En | MEDLINE | ID: mdl-16015036

Subject(s)

Antimetabolites, Antineoplastic/administration & dosage; Antineoplastic Combined Chemotherapy Protocols/therapeutic use; Camptothecin/analogs & derivatives; Colorectal Neoplasms/drug therapy; Drug Resistance, Neoplasm; Fluorouracil/administration & dosage; Adult; Aged; Camptothecin/administration & dosage; Colorectal Neoplasms/pathology; Disease Progression; Drug Administration Schedule; Female; Humans; Irinotecan; Male; Middle Aged; Organoplatinum Compounds/administration & dosage; Oxaliplatin; Retrospective Studies; Treatment Outcome

Search on Google

Add to My VHL

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Camptothecin / Colorectal Neoplasms / Antineoplastic Combined Chemotherapy Protocols / Drug Resistance, Neoplasm / Fluorouracil / Antimetabolites, Antineoplastic Type of study: Observational_studies / Risk_factors_studies Limits: Adult / Aged / Female / Humans / Male / Middle aged Language: En Journal: Oncology Year: 2005 Document type: Article Affiliation country: Italy Country of publication: Switzerland

Search on Google

Add to My VHL

XML

PubMed Links